Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Probably not equal to the orders to end of April, what are payment terms? 30 days invoice period?
I doubt they are asking for payment up front.
Does anybody know?
.
Exactly - taking Wuhan as an example - where they are about to test 11 million residents in one go. I can see this happening in repeatedly when trying to track and trace clusters of infection across the world.
Patience is key.
A quick reminder of the last RNS setting out potentially massive revenue generators:
Manufacturing partnership agreements with six sub-contract manufacturers in addition to it's own manufacturing sites - to scale-up its manufacturing outputs beyond eight million tests per month when necessary.
As we know, this is one of few fully approved in production tests. The market is huge!
The Launch of d-PCR - bypassing the current reagent shortages and speeding up the test.
Further expansion into the US market, where they are targeting a huge number of tests.
And based on past RNS - there is bound to be a couple of surprises in there too!
GLA!
CE Marking is targeted for next week and the market for tests is growing. This seems like a bit of a no brainier in the medium term.
BBC News - Coronavirus: Government 'may not meet' 100,000 test target
https://www.bbc.co.uk/news/uk-52484345
Some key points:
Chris Hopson, chief executive of NHS Providers, which represents hospitals and NHS trusts in England, said the UK should replicate mass testing capacity that has been seen in countries such as Germany and South Korea.
In order to exit lockdown, Mr Hopson said the 800,000 people who work for the NHS would need to be tested around once a week.
TheOriginalNova I read it that they are supplying and ensuring the testing is done correctly (hence helping with the workflow), and that the development referred to development of the direct to pcr tech.
1) Order updates for 80+ countries (Including UK, Ireland, Europe, India, Indonesia, Saudi Arabia, US, Argentina, Thailand, Philippines).
2) Direct-to-PCR extraction technique update - removing reliance for reagents currently in demand and speeding up the test
3) Confirmation of increases to manufacturing capacity from 4 million (achieved now) to 8 million (aiming for by c.15th July).
4) Confirmation of additional capacity options being explored with UK manufacturing partners.
5) Progress of collaboration with AZ, GSK and UoC.
All above taken from updates listed here: https://novacyt.com/news-and-events/
By no means an insignificant list IMO - if I've missed anything feel free to shout up....
I wonder, would they also be looking at expanding production in Germany (by BioType or a partner there)?
GLA
Apologies if this has been posted before and I missed it. The price they are charging per test is interesting:
£385 + vat
https://privateharleystreetclinic.com/products/covid-19-test
Hi,
Can somebody please remind me where the info on price per kit and profit per test assumptions I've seen on here in the past came from please?
Thanks for your continued level headed posts vanv, richken and silver51 - helped me loads!
Thanks very much.
GLA